Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
Advanced Search
Pennsylvania House of Representatives
05/13/2024 11:26 AM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20210&cosponId=36009
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


House of Representatives
Session of 2021 - 2022 Regular Session

MEMORANDUM

Posted: July 22, 2021 11:49 AM
From: Representative Dawn W. Keefer
To: All House members
Subject: Coronavirus Infection Medication Act
 
I will be introducing legislation to allow for the prescribing and dispensing of off-label drugs approved by the United States Food and Drug Administration to treat Coronavirus infections causing respiratory-syndrome-related illnesses.
 
Specifically, my legislation would allow prescribers to prescribe and require a pharmacist to dispense a therapeutic drug approved by the United States FDA so long as it is in accordance with a prescription drug order and with the patient’s consent. In addition, my legislation will allow for drugs such as hydroxychloroquine sulfate and ivermectin to be used at home or early-stage outpatient or hospital inpatient for individuals who wish to treat coronavirus infections causing respiratory-syndrome-related illnesses.
 
I hope you will join me in co-sponsoring this legislation. 

View Attachment

Introduced as HB1741